The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran

Clinical Infectious Diseases

Volumn 36, Issue 12, 2003, Pages 1613-1618

  Mardani, M ^a,d   Jahromi, M Keshtkar ^a   Naieni, K Holakouie ^b   Zeinali, M ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN; ANTIVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAIRO VIRUS; PRIORITY JOURNAL; SURVIVAL; TABLET FORMULATION; VIRUS HEMORRHAGIC FEVER; CLINICAL TRIAL; DRUG EFFECT; EPIDEMIC; IRAN; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IRAN; MALE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0037871884     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375058     Document Type: Article

References (13)

1. Burt FJ, Leman PA, Smith JF, Swanepoel R. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo hemorrhagic fever. J Virol Methods 1998; 70:129-37.
2. Tignor GH, Hanham CA. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 1993; 22:309-325.
3. Van de wal BW, Joubert JR, Van Eeden PJ, King JB. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. IV. Preventive and prophylactic measures. S Afr Med J 1985; 68:729-32.
4. Swanepoel R, Leman P, Abbott JC, et al. Epidemiology, diagnosis, clinical pathology, and treatment of Crimean-Congo haemorrhagic fever (CCHF) in South Africa [abstract P 70-003]. In: Program and abstracts of the VIIIth International Congress of Virology (Berlin). 1990:430.
5. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979; 15:307-417.
6. Suleiman MN, Muscat-Baron JM, Harries JR, et al. Crimean-Congo hemorrhagic fever in Dubai: an outbreak at the Rashid Hospital. Lancet 1980; 2:939-41.
7. Van Eeden PJ, Van Eeden SF, Joubert JR, King JB, Van de wal BW, Michell WL. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. II. Management of patients. S Afr Med J 1985; 68:718-21.
8. Watts DM, Ussery MA, Nash D, Peters CJ. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg 1989; 41:581-5.
9. Fisher-Hoch SP, Khan JK, Rehman S, et al. Crimean-Congo hemorrhagic fever treated with oral ribavirin. Lancet 1995; 346:472-5.
10. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious disease. 5th ed. Philadelphia: Churchill Livingstone, 2000:477-9, 1849-53, 1860-1.
11. World Health Organization (WHO). Crimean-Congo hemorrhagic fever. World Health Organization fact sheet no. 208. Geneva: 1998.
12. Lazarev VN. Treatment of Crimean hemorrhagic fever patients with convalescent sera [in Russian]. In: Chumakov MP, ed. Arboviruses. Mater 16 Nauch Sess Inst Polio Virus Entsef 1969; 2:142-3.
13. Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 1988; 37(Suppl 3):S1-16.